NPM1 and anaplastic large cell lymphoma: In 70% of systemic ALK+ ALCL cases, patients present with the t(2;5)(p23;35) translocation, resulting in abundant cytoplasmic and nuclear expression of the Nucleophosmin-Anaplastic Lymphoma Kinase (NPM-ALK) chimeric protein [2].